Medi Assist Healthcare Services Limited
Medi Assist Healthcare Services Limited (MEDIASSIST) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Financial Services›Financial Services›Insurance›Insurance Distributors
mediassist.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 166 Cr | 167 Cr | 168 Cr | 181 Cr | 186 Cr | 189 Cr | 191 Cr | 233 Cr | 240 Cr | 242 Cr | 237 Cr |
| Operating expenses (approx.) | 132 Cr | 130 Cr | 132 Cr | 142 Cr | 146 Cr | 148 Cr | 149 Cr | 193 Cr | 195 Cr | 194 Cr | 189 Cr |
| EBITDA | 34 Cr | 37 Cr | 35 Cr | 38 Cr | 40 Cr | 41 Cr | 42 Cr | 40 Cr | 45 Cr | 48 Cr | 48 Cr |
| OPM % | 20.4% | 22.2% | 21.0% | 21.3% | 21.3% | 21.6% | 22.0% | 17.1% | 18.6% | 19.9% | 20.3% |
| Other income | 4 Cr | 4 Cr | 5 Cr | 6 Cr | 4 Cr | 8 Cr | 7 Cr | 2 Cr | 8 Cr | 1 Cr | 10 Cr |
| Interest | 1 Cr | 0.78 Cr | 2 Cr | 2 Cr | 2 Cr | 4 Cr | 5 Cr | 8 Cr | 8 Cr | 0.65 Cr | 2 Cr |
| Depreciation | 11 Cr | 12 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 21 Cr | 21 Cr | 21 Cr | 22 Cr |
| Profit before tax | 26 Cr | 28 Cr | 25 Cr | 30 Cr | 27 Cr | 30 Cr | 31 Cr | 13 Cr | 8 Cr | 28 Cr | 35 Cr |
| Tax % | 17.2% | 9.0% | 24.0% | 28.9% | -10.0% | 28.0% | 25.8% | 40.1% | 51.2% | -95.2% | 20.9% |
| Net profit | 21 Cr | 26 Cr | 19 Cr | 21 Cr | 30 Cr | 22 Cr | 23 Cr | 8 Cr | 4 Cr | 54 Cr | 28 Cr |
| EPS (₹) | ₹2.98 | ₹3.64 | ₹2.68 | ₹2.99 | ₹4.20 | ₹3.05 | ₹3.18 | ₹1.13 | ₹0.51 | ₹7.33 | ₹3.71 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 635 Cr | 723 Cr | 905 Cr | Sign in for TTM |
| Operating expenses (approx.) | 501 Cr | 569 Cr | 730 Cr | Sign in for TTM |
| EBITDA | 133 Cr | 154 Cr | 175 Cr | Sign in for TTM |
| OPM % | 21.0% | 21.3% | 19.3% | Sign in for TTM |
| Other income | 18 Cr | 24 Cr | 18 Cr | Sign in for TTM |
| Interest | 3 Cr | 10 Cr | 21 Cr | Sign in for TTM |
| Depreciation | 43 Cr | 56 Cr | 77 Cr | Sign in for TTM |
| Profit before tax | 82 Cr | 112 Cr | 80 Cr | Sign in for TTM |
| Tax % | 16.0% | 18.1% | -11.1% | Sign in for TTM |
| Net profit | 69 Cr | 92 Cr | 89 Cr | Sign in for TTM |
| EPS (₹) | ₹9.71 | ₹12.91 | ₹12.14 | Sign in for TTM |
| Dividend payout % | 18.8% | 30.7% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 35 Cr | 35 Cr | 37 Cr |
| Reserves | 437 Cr | 506 Cr | 802 Cr |
| Borrowings | — | 150 Cr | — |
| Other liabilities | 369 Cr | 456 Cr | 520 Cr |
| Total liabilities | 851 Cr | 1,158 Cr | 1,372 Cr |
| Fixed assets (net) | 55 Cr | 32 Cr | 43 Cr |
| CWIP | 0 Cr | 0 Cr | 0 Cr |
| Investments | 77 Cr | 274 Cr | 158 Cr |
| Trade receivables | 179 Cr | 221 Cr | 287 Cr |
| Cash & bank | 51 Cr | 83 Cr | 55 Cr |
| Other assets | 490 Cr | 548 Cr | 830 Cr |
| Total assets | 851 Cr | 1,158 Cr | 1,372 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operating activity | 66 Cr | 138 Cr | 118 Cr |
| Cash from investing | -55 Cr | -218 Cr | -160 Cr |
| Cash from financing | -15 Cr | 112 Cr | 12 Cr |
| Net cash flow | -3 Cr | 32 Cr | -28 Cr |
| Free cash flow (OCF − Capex) | 48 Cr | 92 Cr | 62 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | 17.6% | 17.4% | 11.9% |
| ROE % | 13.9% | 16.5% | 10.3% |
| Debtor days | 103 | 111 | 115 |
| Inventory days | 0 | 0 | 0 |
| Days payable | 24 | 15 | 18 |
| Cash conversion cycle | 78 | 96 | 97 |
| Debt / equity | 0.00 | 0.28 | 0.0061 |
| Current ratio | 1.50 | 1.49 | 1.34 |
| Net debt / EBITDA | -0.38 | 0.44 | -0.31 |
Compare with peers
Loading peers…